| 1 |
To re-elect Dr. Hadar Ron to serve as a Class I director of the Company, and to hold office until the annual general meeting of shareholders to be held in 2029 and until her successor is duly elected and qualified, or until her earlier resignation or retirement. |
✓ For(167.296)
|
| 2 |
To approve the re-appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member of PricewaterhouseCoopers International Limited, as the Company’s independent auditors for the fiscal year ending December 31, 2026, and its service until the annual general meeting of shareholders to be held in 2027. |
✓ For(167.296)
|
| 3 |
To approve the grant of a total of 6,000 restricted share units under the Company's 2018 Incentive Plan to the following non-executive directors: Dr. Shlomo Nass (2,000 RSUs), Dr. Hadar Ron (2,000 RSUs) and Mr. Nadav Kenneth (2,000 RSUs), half of which shall vest on February 15, 2027, and the remaining half of which shall vest on February 15, 2028, subject to their continued service on the date of vesting. |
✓ For(167.296)
|
| 4 |
To approve the compensation terms of the Special Committee of the Board, as set forth in Proposal 4 of the Proxy Statement dated June 18, 2026. |
✗ Against(167.296)
|
rebel Financial
